SPOTLIGHT -
Moving Forward From Monotherapy in HCC
Ann-Lii Cheng, MD, discusses where the of hepatocellular carcinoma is headed.
Phase III Findings for Lenvatinib in HCC
Ann-Lii Cheng, MD, discusses a phase III trial of lenvatinib vs sorafenib in the first-line treatment of patients with unresectable hepatocellular carcinoma.